New Mountain Capital will sell ILC Dover to Ingersoll Rand for about $2.3 billion, according to industry reports.

ILC, founded in 1947 and based in Frederica, Del., designs and produces solutions for the biopharmaceutical, pharmaceutical and medical device…

Arsenal Capital Partners will acquire Fortrea’s enabling services segment and patient access businesses, according to a news release.

Fortea (Nasdaq: FTRE), a global clinical research organization based in Research Triangle Park, N.C., is divesting its Endpoint Clinical and Fortrea…

Linden Capital Partners has announced the acquisition of Alcresta Therapeutics.

Alcresta, founded in 2011 and based in Newton, Mass., develops and commercializes enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases.

Linden…

Vesey Street Capital Partners (VSCP) has announced the completion of a majority recapitalization of Inceptua Group.

Inceptua, founded in 1997 and with its U.S. office in Princeton, N.J., is provider of clinical trial supplies and related services.

VSCP…

Windjammer Capital has announced it has acquired Bio X Cell (BXC).

BXC, founded in 1997 and based in Lebanon, N.H., is a producer of monoclonal antibodies for use in both in vivo and in vitro pre-clinical research applications.

Windjammer…

OrbiMed has announced it has raised more than $4.3 billion in commitments for its latest private investment funds.

These new funds include OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit Opportunities IV.

OrbiMed, headquartered…

QHP Capital has announced it has acquired Applied StemCell.

Applied StemCell, founded in 2008 and based in Milpitas, Calif., develops gene editing and stem cell technology platforms designed to help advance broader cell therapy manufacturing.

QHP, based in…

Gurnet Point Capital and Novo Holdings have completed their acquisition of Paratek Pharmaceuticals in a deal valued at $462 million, according to a news release.

Paratek, founded in 1996 and based in Boston, is a commercial-stage biopharmaceutical company…